{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:55:58Z","timestamp":1793328958935,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50051-x","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:24:05Z","timestamp":1779186245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of stem cell therapy on brain metabolic profile in cerebral palsy assessed by magnetic resonance spectroscopy in a randomized clinical trial"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-9935","authenticated-orcid":false,"given":"Melika","family":"Jameie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Mozafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadis","family":"Farazmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Khodadoust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Majmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Amanollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Zarrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masood","family":"Ghahvechi Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Reza","family":"Moaiedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Shervin Badv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massoud","family":"Vosough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Ali","family":"Hamidieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Montazerlotfelahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Reza","family":"Tavasoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safdar","family":"Masoomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5483-6549","authenticated-orcid":false,"given":"Mahmoud Reza","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"50051_CR1","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2147\/NDT.S235165","volume":"16","author":"M Sadowska","year":"2020","unstructured":"Sadowska, M., Sarecka-Hujar, B. & Kopyta, I. Cerebral palsy: Current opinions on definition, epidemiology, risk factors, classification and treatment options. Neuropsychiatr. Dis. Treat. 16, 1505\u20131518 (2020).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"50051_CR2","first-page":"35","volume":"109","author":"C Christine","year":"2007","unstructured":"Christine, C. et al. Recommendations from the SCPE collaborative group for defining and classifying cerebral palsy. Dev. Med. Child Neurol. Suppl. 109, 35\u201338 (2007).","journal-title":"Dev. Med. Child Neurol. Suppl."},{"issue":"12","key":"50051_CR3","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/dmcn.15346","volume":"64","author":"S McIntyre","year":"2022","unstructured":"McIntyre, S. et al. Global prevalence of cerebral palsy: A systematic analysis. Dev. Med. Child Neurol. 64(12), 1494\u20131506 (2022).","journal-title":"Dev. Med. Child Neurol."},{"key":"50051_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2023.02.005","volume":"143","author":"F Barron-Garza","year":"2023","unstructured":"Barron-Garza, F. et al. Incidence of cerebral palsy, risk factors, and neuroimaging in Northeast Mexico. Pediatr. Neurol. 143, 50\u201358 (2023).","journal-title":"Pediatr. Neurol."},{"issue":"1","key":"50051_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0004-9514(14)60183-5","volume":"49","author":"DS Reddihough","year":"2003","unstructured":"Reddihough, D. S. & Collins, K. J. The epidemiology and causes of cerebral palsy. Aust. J. Physiother. 49(1), 7\u201312 (2003).","journal-title":"Aust. J. Physiother."},{"key":"50051_CR6","unstructured":"NIH. Cerebral Palsy. https:\/\/www.ninds.nih.gov\/health-information\/disorders\/cerebral-palsy\u00a0(2024)."},{"issue":"1","key":"50051_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang, D. M. et al. Stem cell-based therapy for human diseases. Signal Transduct. Target. Ther. 7(1), 272 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"50051_CR8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.2217\/rme-2019-0119","volume":"15","author":"S Reyhani","year":"2020","unstructured":"Reyhani, S., Abbaspanah, B. & Mousavi, S. H. Umbilical cord-derived mesenchymal stem cells in neurodegenerative disorders: From literature to clinical practice. Regen. Med. 15(4), 1561\u20131578 (2020).","journal-title":"Regen. Med."},{"key":"50051_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-024-05072-3","author":"A Akat","year":"2024","unstructured":"Akat, A. & Kara\u00f6z, E. A systematic review of cell therapy modalities and outcomes in cerebral palsy. Mol. Cell. Biochem. https:\/\/doi.org\/10.1007\/s11010-024-05072-3 (2024).","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"50051_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jcyt.2021.07.001","volume":"24","author":"MCB Paton","year":"2022","unstructured":"Paton, M. C. B. et al. Safety of allogeneic umbilical cord blood infusions for the treatment of neurological conditions: A systematic review of clinical studies. Cytotherapy 24(1), 2\u20139 (2022).","journal-title":"Cytotherapy"},{"issue":"2","key":"50051_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/jpc.15329","volume":"57","author":"MCB Paton","year":"2021","unstructured":"Paton, M. C. B. et al. Fifteen years of human research using stem cells for cerebral palsy: A review of the research landscape. J. Paediatr. Child Health. 57(2), 295\u2013296 (2021).","journal-title":"J. Paediatr. Child Health."},{"issue":"1","key":"50051_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12967-017-1149-0","volume":"15","author":"X Liu","year":"2017","unstructured":"Liu, X. et al. Comparative analysis of curative effect of bone marrow mesenchymal stem cell and bone marrow mononuclear cell transplantation for spastic cerebral palsy. J. Transl. Med. 15(1), 48. (2017).","journal-title":"J. Transl. Med."},{"issue":"2","key":"50051_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/0963689717729379","volume":"27","author":"L Huang","year":"2018","unstructured":"Huang, L. et al. A randomized, placebo-controlled trial of human umbilical cord blood mesenchymal stem cell infusion for children with cerebral palsy. Cell Transplant. 27(2), 325\u2013334 (2018).","journal-title":"Cell Transplant."},{"issue":"1","key":"50051_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13287-019-1545-x","volume":"11","author":"J Gu","year":"2020","unstructured":"Gu, J. et al. Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: A randomized, controlled trial. Stem Cell Res. Ther. 11(1), 43. (2020).","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"50051_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s13287-021-02513-4","volume":"12","author":"M Amanat","year":"2021","unstructured":"Amanat, M. et al. Clinical and imaging outcomes after intrathecal injection of umbilical cord tissue mesenchymal stem cells in cerebral palsy: A randomized double-blind sham-controlled clinical trial. Stem Cell Res. Ther. 12(1), 439 (2021).","journal-title":"Stem Cell Res. Ther."},{"issue":"12","key":"50051_CR16","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/dmcn.15325","volume":"64","author":"JM Sun","year":"2022","unstructured":"Sun, J. M. et al. Motor function and safety after allogeneic cord blood and cord tissue-derived mesenchymal stromal cells in cerebral palsy: An open-label, randomized trial. Dev. Med. Child Neurol. 64(12), 1477\u20131486 (2022).","journal-title":"Dev. Med. Child Neurol."},{"issue":"1","key":"50051_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12883-022-02636-y","volume":"22","author":"M Zarrabi","year":"2022","unstructured":"Zarrabi, M. et al. The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: A randomized double-blind sham-controlled clinical trial. BMC Neurol. 22(1), 123 (2022).","journal-title":"BMC Neurol."},{"key":"50051_CR18","doi-asserted-by":"publisher","first-page":"5701920","DOI":"10.1155\/2020\/5701920","volume":"2020","author":"B Xie","year":"2020","unstructured":"Xie, B. et al. Therapeutic Evidence of Human Mesenchymal Stem Cell Transplantation for Cerebral Palsy: A Meta-Analysis of Randomized Controlled Trials. Stem Cells Int 2020, 5701920 (2020).","journal-title":"Stem Cells Int"},{"issue":"12","key":"50051_CR19","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.jcyt.2013.06.001","volume":"15","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. Effects of bone marrow mesenchymal stromal cells on gross motor function measure scores of children with cerebral palsy: A preliminary clinical study. Cytotherapy 15(12), 1549\u20131562 (2013).","journal-title":"Cytotherapy"},{"key":"50051_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1479-5876-11-21","volume":"11","author":"G Chen","year":"2013","unstructured":"Chen, G. et al. Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy. J. Transl. Med. 11, 21 (2013).","journal-title":"J. Transl. Med."},{"issue":"3","key":"50051_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/stem.1304","volume":"31","author":"K Min","year":"2013","unstructured":"Min, K. et al. Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: A double-blind, randomized, placebo-controlled trial. Stem Cells 31(3), 581\u2013591 (2013).","journal-title":"Stem Cells"},{"issue":"1","key":"50051_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s13287-020-02020-y","volume":"11","author":"K Min","year":"2020","unstructured":"Min, K. et al. Potentiation of cord blood cell therapy with erythropoietin for children with CP: A 2 \u00d7 2 factorial randomized placebo-controlled trial. Stem Cell Res. Ther. 11(1), 509 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"50051_CR23","first-page":"569","volume":"26","author":"M Nouri","year":"2024","unstructured":"Nouri, M. et al. Cell-based therapy for cerebral palsy: a puzzle in progress. Cell J. 26, 569 (2024).","journal-title":"Cell J."},{"key":"50051_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.844911","volume":"13","author":"R Wu","year":"2022","unstructured":"Wu, R. et al. Metabolic assessment of cerebral palsy with normal clinical MRI using (18)F-FDG PET imaging: A preliminary report. Front. Neurol. 13, 844911 (2022).","journal-title":"Front. Neurol."},{"issue":"4","key":"50051_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1017\/S0012162206000612","volume":"48","author":"W Kulak","year":"2006","unstructured":"Kulak, W. et al. Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study. Dev Med Child Neurol 48(4), 285\u2013289 (2006).","journal-title":"Dev Med Child Neurol"},{"key":"50051_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9020027","author":"Z Alpay Savasan","year":"2019","unstructured":"Alpay Savasan, Z. et al. Metabolomic profiling of cerebral palsy brain tissue reveals novel central biomarkers and biochemical pathways associated with the disease: A pilot study. Metabolites https:\/\/doi.org\/10.3390\/metabo9020027 (2019).","journal-title":"Metabolites"},{"key":"50051_CR27","first-page":"3833","volume":"86","author":"M Noha","year":"2018","unstructured":"Noha, M., Rania, S. A. & Al-Shahawy, Z. The role of magnetic resonance imaging in the evaluation of children with cerebral palsy: A proton magnetic resonance spectroscopy study. Med. J. Cairo Univ. 86, 3833\u20133838 (2018).","journal-title":"Med. J. Cairo Univ."},{"issue":"1","key":"50051_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/0883073808321058","volume":"24","author":"W Kulak","year":"2009","unstructured":"Kulak, W. et al. An age and gender dependency of metabolite concentrations in basal ganglia in children with spastic diplegia: Proton magnetic resonance spectroscopy study. J. Child Neurol. 24(1), 73\u201379 (2009).","journal-title":"J. Child Neurol."},{"issue":"8","key":"50051_CR29","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1001\/archneur.56.8.919","volume":"56","author":"TM Rudkin","year":"1999","unstructured":"Rudkin, T. M. & Arnold, D. L. Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders. Arch. Neurol. 56(8), 919\u2013926 (1999).","journal-title":"Arch. Neurol."},{"issue":"4","key":"50051_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/archdischild-2017-312839","volume":"103","author":"KA Manias","year":"2018","unstructured":"Manias, K. A. & Peet, A. What is MR spectroscopy?. Arch. Dis. Child. Educ. Pract. Ed. 103(4), 213\u2013216 (2018).","journal-title":"Arch. Dis. Child. Educ. Pract. Ed."},{"key":"50051_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/978-1-61737-992-5_9","volume-title":"Magnetic Resonance Neuroimaging: Methods and Protocols","author":"H Zhu","year":"2011","unstructured":"Zhu, H. & Barker, P. B. MR Spectroscopy and Spectroscopic Imaging of the Brain. In Magnetic Resonance Neuroimaging: Methods and Protocols (eds Modo, M. & Bulte, J. W. M.) 203\u2013226 (Humana Press, 2011)."},{"issue":"8","key":"50051_CR32","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s00701-012-1418-x","volume":"154","author":"J Guo","year":"2012","unstructured":"Guo, J. et al. The relationship between Cho\/NAA and glioma metabolism: Implementation for margin delineation of cerebral gliomas. Acta Neurochir (Wien) 154(8), 1361\u20131370 (2012).","journal-title":"Acta Neurochir (Wien)"},{"key":"50051_CR33","unstructured":"BOBATH, K., The neuro-developmental treatment. Management of motor disorders of children with cerebral palsy. (1984)."},{"issue":"7","key":"50051_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1469-8749.2002.tb00306.x","volume":"44","author":"V Knox","year":"2002","unstructured":"Knox, V. & Evans, A. L. Evaluation of the functional effects of a course of Bobath therapy in children with cerebral palsy: A preliminary study. Dev. Med. Child Neurol. 44(7), 447\u2013460 (2002).","journal-title":"Dev. Med. Child Neurol."},{"key":"50051_CR35","first-page":"8","volume":"109","author":"P Rosenbaum","year":"2007","unstructured":"Rosenbaum, P. et al. A report: The definition and classification of cerebral palsy April 2006. Dev. Med. Child Neurol. Suppl. 109, 8\u201314 (2007).","journal-title":"Dev. Med. Child Neurol. Suppl."},{"issue":"20","key":"50051_CR36","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical, A.","year":"2013","unstructured":"World Medical, A. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 310(20), 2191\u20132194 (2013).","journal-title":"JAMA"},{"issue":"3","key":"50051_CR37","first-page":"199","volume":"47","author":"ICH Harmonised Tripartite Guideline","year":"2001","unstructured":"ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice. J. Postgrad. Med. 47(3), 199\u2013203 (2001).","journal-title":"J. Postgrad. Med."},{"issue":"1","key":"50051_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/hum.2010.197","volume":"22","author":"L Senseb\u00e9","year":"2011","unstructured":"Senseb\u00e9, L., Bourin, P. & Tarte, K. Good manufacturing practices production of mesenchymal stem\/stromal cells. Hum. Gene Ther. 22(1), 19\u201326 (2011).","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"50051_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz, K. F. et al. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. BMC Med. 8(1), 18 (2010).","journal-title":"BMC Med."},{"issue":"10","key":"50051_CR40","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.humimm.2022.03.002","volume":"83","author":"DS Mangum","year":"2022","unstructured":"Mangum, D. S. & Caywood, E. A clinician\u2019s guide to HLA matching in allogeneic hematopoietic stem cell transplant. Hum. Immunol. 83(10), 687\u2013694 (2022).","journal-title":"Hum. Immunol."},{"issue":"2","key":"50051_CR41","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1469-8749.2007.00144.x","volume":"49","author":"I Kr\u00e4geloh-Mann","year":"2007","unstructured":"Kr\u00e4geloh-Mann, I. & Horber, V. The role of magnetic resonance imaging in elucidating the pathogenesis of cerebral palsy: A systematic review. Dev. Med. Child Neurol. 49(2), 144\u2013151 (2007).","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"50051_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4), 315\u2013317 (2006).","journal-title":"Cytotherapy"},{"issue":"11","key":"50051_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082746","volume":"8","author":"M Tomiyasu","year":"2013","unstructured":"Tomiyasu, M. et al. Neonatal brain metabolite concentrations: An in vivo magnetic resonance spectroscopy study with a clinical MR system at 3 tesla. PLoS One. 8(11), e82746 (2013).","journal-title":"PLoS One."},{"issue":"7","key":"50051_CR44","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.4103\/1673-5374.300979","volume":"16","author":"ZY Lv","year":"2021","unstructured":"Lv, Z. Y., Li, Y. & Liu, J. Progress in clinical trials of stem cell therapy for cerebral palsy. Neural Regen. Res. 16(7), 1377\u20131382 (2021).","journal-title":"Neural Regen. Res."},{"issue":"7","key":"50051_CR45","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jcyt.2015.02.010","volume":"17","author":"YA Romanov","year":"2015","unstructured":"Romanov, Y. A. et al. Human allogeneic AB0\/Rh-identical umbilical cord blood cells in the treatment of juvenile patients with cerebral palsy. Cytotherapy 17(7), 969\u2013978 (2015).","journal-title":"Cytotherapy"},{"issue":"5","key":"50051_CR46","doi-asserted-by":"publisher","first-page":"e2024068999","DOI":"10.1542\/peds.2024-068999","volume":"155","author":"M Finch-Edmondson","year":"2025","unstructured":"Finch-Edmondson, M. et al. Cord blood treatment for children with cerebral palsy: Individual participant data meta-analysis. Pediatrics 155(5), e2024068999 (2025).","journal-title":"Pediatrics"},{"key":"50051_CR47","doi-asserted-by":"publisher","first-page":"1006845","DOI":"10.3389\/fbioe.2022.1006845","volume":"10","author":"J Qu","year":"2022","unstructured":"Qu, J. et al. Efficacy and safety of stem cell therapy in cerebral palsy: A systematic review and meta-analysis. Front. Bioeng. Biotechnol. 10, 1006845 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"5","key":"50051_CR48","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3346\/jkms.2017.32.5.873","volume":"32","author":"BY Hong","year":"2017","unstructured":"Hong, B. Y. et al. Factors influencing the gross motor outcome of intensive therapy in children with cerebral palsy and developmental delay. J. Korean Med. Sci. 32(5), 873 (2017).","journal-title":"J. Korean Med. Sci."},{"issue":"1","key":"50051_CR49","doi-asserted-by":"publisher","first-page":"e0312378","DOI":"10.1371\/journal.pone.0312378","volume":"20","author":"Y Jiang","year":"2025","unstructured":"Jiang, Y. et al. White matter lesions and DTI metrics related to various types of dysfunction in cerebral palsy: A meta-analysis and systematic review. PLoS One. 20(1), e0312378 (2025).","journal-title":"PLoS One."},{"key":"50051_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.936130","volume":"10","author":"C Gire","year":"2022","unstructured":"Gire, C. et al. A correlation between magnetic resonance spectroscopy (1-H MRS) and the neurodevelopment of two-year-olds born preterm in an EPIRMEX cohort study. Front. Pediatr. 10, 936130 (2022).","journal-title":"Front. Pediatr."},{"issue":"1","key":"50051_CR51","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s43055-021-00578-y","volume":"52","author":"FIS Elshal","year":"2021","unstructured":"Elshal, F. I. S. et al. Magnetic resonance imaging and spectroscopy in evaluation of hypoxic ischemic encephalopathy in pediatric age group. Egypt. J. Radiol. Nucl. Med. 52(1), 198 (2021).","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"key":"50051_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2016.00057","volume":"7","author":"P Rumajogee","year":"2016","unstructured":"Rumajogee, P. et al. Rodent hypoxia\u2013ischemia models for cerebral palsy research: A systematic review. Front. Neurol. 7, 57 (2016).","journal-title":"Front. Neurol."},{"issue":"1","key":"50051_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/pr.2013.62","volume":"74","author":"D Card","year":"2013","unstructured":"Card, D. et al. Brain metabolite concentrations are associated with illness severity scores and white matter abnormalities in very preterm infants. Pediatr. Res. 74(1), 75\u201381 (2013).","journal-title":"Pediatr. Res."},{"issue":"5","key":"50051_CR54","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/153537020623100503","volume":"231","author":"V Michel","year":"2006","unstructured":"Michel, V. et al. Choline transport for phospholipid synthesis. Exp Biol Med (Maywood) 231(5), 490\u2013504 (2006).","journal-title":"Exp Biol Med (Maywood)"},{"key":"50051_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/nu12061731","author":"E Derbyshire","year":"2020","unstructured":"Derbyshire, E. & Obeid, R. Choline, neurological development and brain function: A systematic review focusing on the first 1000 days. Nutrients https:\/\/doi.org\/10.3390\/nu12061731 (2020).","journal-title":"Nutrients"},{"issue":"4","key":"50051_CR56","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1203\/01.PDR.0000139928.60530.7D","volume":"56","author":"S Ashwal","year":"2004","unstructured":"Ashwal, S. et al. Proton spectroscopy detected Myoinositol in children with traumatic brain injury. Pediatr. Res. 56(4), 630\u2013638 (2004).","journal-title":"Pediatr. Res."},{"issue":"6","key":"50051_CR57","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1203\/00006450-200112000-00011","volume":"50","author":"NJ Robertson","year":"2001","unstructured":"Robertson, N. J. et al. Early increases in brain myo-Inositol measured by proton magnetic resonance spectroscopy in term infants with neonatal encephalopathy. Pediatr. Res. 50(6), 692\u2013700 (2001).","journal-title":"Pediatr. Res."},{"key":"50051_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.800273","volume":"13","author":"C Bertran-Cobo","year":"2022","unstructured":"Bertran-Cobo, C. et al. A neurometabolic pattern of elevated Myo-Inositol in children who are HIV-exposed and uninfected: A South African birth cohort study. Front. Immunol. 13, 800273 (2022).","journal-title":"Front. Immunol."},{"issue":"6","key":"50051_CR59","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/brain\/awh153","volume":"127","author":"KTM Fernando","year":"2004","unstructured":"Fernando, K. T. M. Elevated white matter myo\u2010inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 127(6), 1361\u20131369 (2004).","journal-title":"Brain"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50051-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50051-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50051-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T01:03:51Z","timestamp":1787101431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50051-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50051"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50051-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board (IRB) of the\n                      Tehran University of Medical Sciences\n                      (TUMS), Tehran, Iran (IR.TUMS.VCRREC.1996.2506; date of approval: 6 June 2017) under the title \u201cEvaluation of the efficacy of allogeneic umbilical cord derived hematopoietic stem cells and mesenchymal stromal cells (UC-MSC) in patients with spastic cerebral palsy: A Clinical trial phase II\u201d. This study followed the ethical principles of the Declaration of Helsinki and Good Clinical Practice. The requirements for Good Manufacturing Practices and Good Tissue Practices were met by all manufacturing procedures and labs. Before enrollment, the parents or legal guardians of all participants provided written informed consent for study participation and publication. Additionally, donors provided written informed consent for the use of allogeneic UC-MSCs and UCB-MNCs in medical research.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25999"}}